The Role of The Cytomegalovirus Antigenemia Assay in the Detection and Prevention of Cytomegalovirus Syndrome and Disease in Solid Organ Transplant Recipients: A Review of the British Columbia Experience | Zendy

Erica D. Greanya | Zendy; Nilufar Partovi | Zendy; Eric M. Yoshida | Zendy; R. Jean Shapiro | Zendy; Robert D. Levy | Zendy; C.H. Sherlock | Zendy; Gwen Stephens | Zendy

Open Access

The Role of The Cytomegalovirus Antigenemia Assay in the Detection and Prevention of Cytomegalovirus Syndrome and Disease in Solid Organ Transplant Recipients: A Review of the British Columbia Experience

Author(s) -

Erica D. Greanya,

Nilufar Partovi,

Eric M. Yoshida,

R. Jean Shapiro,

Robert D. Levy,

C.H. Sherlock,

Gwen Stephens

Publication year - 2005

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2005/679386

Subject(s) - medicine , ganciclovir , cytomegalovirus , disease , transplantation , human cytomegalovirus , immunology , gastroenterology , intensive care medicine , viral disease , virus , herpesviridae

The pp65 cytomegalovirus (CMV) antigenemia assay has been used as a means of guiding the pre-emptive therapy of CMV disease in solid organ transplant (SOT) recipients. Recently, concerns have been raised regarding the utility of the test to accurately and precisely detect viral activity early enough to reduce the morbidity and mortality associated with CMV OBJECTIVE: To determine the performance characteristics of the method of antigenemia testing of SOT recipients used at Vancouver General Hospital, Vancouver, British Columbia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research